Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Share on Pinterest An SGLT-2 inhibitor drug plus a moderately calorie-restrictive diet may be the best approach for achieving diabetes remission. Image credit: Xvision/Getty Images. About 828 ...

A groundbreaking medication capable of preventing type 2 diabetes by up to 85% is offering new hope to those at risk, a breakthrough highlighted by Al-Ahli Hospital doctors. Endocrinology ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been ...

LOS ANGELES - A new clinical trial in The BMJ found that combining calorie restriction with the diabetes drug dapagliflozin reversed type 2 diabetes in nearly half of participants. The approach ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...

However, the study also found that certain diabetes medications like pioglitazone, antipsychotic prescriptions and benzodiazepines, which are generally used to treat anxiety, insomnia and seizures ...

THESE DRUGS COULD POSSIBLY PREVENT HEART ATTACK AND STROKE. THE RESULTS ARE PROMISING FOR HEART PATIENTS.. THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS ...